AlphaCentric Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$275K Sell
2024
Q3
$1.13M Hold
2024
Q2
$866K Hold
2024
Q1
$723K Sell
2023
Q4
$688K Sell
2023
Q3
$726K Buy